BioScrip Reports Second Quarter 2016 Financial Results
Q2 Consolidated Revenue of $232.5 Million, Loss from continuing operations, net of income taxes of $(8.3) Million and Adjusted EBITDA of $10.4 Million Full Year 2016 Guidance Updated to Reflect Pending Acquisition of Home Solutions DENVER, Aug. 08, 2016 ( …